Rani Therapeutics Holdings (RANI) Debt Ratio (2020 - 2025)
Historic Debt Ratio for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to 1.34.
- Rani Therapeutics Holdings' Debt Ratio rose 10537.74% to 1.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.34, marking a year-over-year increase of 10537.74%. This contributed to the annual value of 0.67 for FY2024, which is 3243.79% up from last year.
- According to the latest figures from Q3 2025, Rani Therapeutics Holdings' Debt Ratio is 1.34, which was up 10537.74% from 1.02 recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Debt Ratio ranged from a high of 1.34 in Q3 2025 and a low of 0.0 during Q2 2022
- In the last 5 years, Rani Therapeutics Holdings' Debt Ratio had a median value of 0.38 in 2023 and averaged 0.43.
- As far as peak fluctuations go, Rani Therapeutics Holdings' Debt Ratio tumbled by 9942.76% in 2022, and later soared by 12179106.54% in 2023.
- Quarter analysis of 5 years shows Rani Therapeutics Holdings' Debt Ratio stood at 0.0 in 2021, then surged by 26499.1% to 0.27 in 2022, then surged by 88.01% to 0.51 in 2023, then surged by 32.44% to 0.67 in 2024, then soared by 98.72% to 1.34 in 2025.
- Its Debt Ratio stands at 1.34 for Q3 2025, versus 1.02 for Q2 2025 and 0.87 for Q1 2025.